| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.56▲ | 1.55▲ | 1.55▲ | 1.54▲ | 1.55▲ |
| MA10 | 1.56▲ | 1.56▲ | 1.55▲ | 1.56▲ | 1.53▲ |
| MA20 | 1.57▲ | 1.55▲ | 1.56▲ | 1.56▲ | 1.86▼ |
| MA50 | 1.55▲ | 1.58▼ | 1.58▼ | 1.56▲ | 2.43▼ |
| MA100 | 1.57▲ | 1.58▼ | 1.59▼ | 1.89▼ | 1.85▼ |
| MA200 | 1.58▼ | 1.66▼ | 1.56▲ | 2.30▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.005▲ | 0.003▲ | -0.004▼ | 0.005▲ |
| RSI | 52.644▲ | 51.057▲ | 50.358▲ | 48.698▼ | 44.032▼ |
| STOCH | 38.095 | 42.199 | 60.871 | 33.698 | 38.425 |
| WILL %R | -42.857 | -25.000 | -20.000▲ | -64.412 | -69.814 |
| CCI | 29.224 | 69.581 | 78.813 | -54.665 | -39.848 |
|
Friday, April 25, 2025 04:32 PM
FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that Nasdaq has ...
|
|
Friday, April 25, 2025 02:50 PM
Celularity (CELU) has paid a fee of $70,000 to Nasdaq, as required by the listing rules, following the receipt of a notification from the latter. Additionally, ...
|
|
Friday, April 25, 2025 02:40 PM
Celularity (CELU) announced that Nasdaq has notified the company that it has not paid certain fees required by Listing Rule 5250(f) and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.545 | 1.59 | 1.507 | 1.571 | 16,500 |
| 30/04/25 | 1.46 | 1.61 | 1.46 | 1.49 | 23,400 |
| 29/04/25 | 1.65 | 1.65 | 1.45 | 1.48 | 58,752 |
| 28/04/25 | 1.68 | 1.68 | 1.54 | 1.564 | 12,800 |
| 25/04/25 | 1.63 | 1.67 | 1.50 | 1.61 | 57,653 |
| 24/04/25 | 1.61 | 1.72 | 1.5345 | 1.69 | 17,242 |
| 23/04/25 | 1.50 | 1.7699 | 1.50 | 1.61 | 79,883 |
| 22/04/25 | 1.52 | 1.54 | 1.475 | 1.49 | 41,700 |
| 21/04/25 | 1.50 | 1.614 | 1.47 | 1.52 | 42,700 |
| 17/04/25 | 1.56 | 1.778 | 1.50 | 1.555 | 56,800 |
|
|
||||
|
|
||||
|
|